CERO
CERo Therapeutics Holdings, Inc. - Common Stock (CERO)
$03
About CERo Therapeutics Holdings, Inc. - Common Stock (CERO)
CERo Therapeutics Holdings, Inc. is an immunotherapy company, which engages in development of engineered T cell therapeutics for the treatment of cancer. Its platform is designed to redirect patient-derived T cells to eliminate tumors, creating Chimeric Engulfment Receptor T (CER-T) cells used for spanning hematological malignancies and solid tumors. The company was founded on June 8, 2021 and is headquartered in Oakland, CA.
Details
Daily high
$0.04
Daily low
$0.03
Price at open
$0.04
52 Week High
$28.40
52 Week Low
$0.03
Market cap
733,300
Dividend yield
0.00%
Volume
70,748
Avg. volume
404,579
P/E ratio
.00
CERo Therapeutics Holdings, Inc. - Common Stock News
Details
Daily high
$0.04
Daily low
$0.03
Price at open
$0.04
52 Week High
$28.40
52 Week Low
$0.03
Market cap
733,300
Dividend yield
0.00%
Volume
70,748
Avg. volume
404,579
P/E ratio
.00